Open AccessBimatoprost/timolol fixed combination (BTFC) in patients with primary open angle glaucoma or ocular hypertension in Greece
Author(s) -
Tryfon Rotsos,
Vasso G. Kliafa,
Kevin J. Asher,
Dimitris Papaconstantinou
Publication year - 2016
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2016.01.12
Subject(s) - medicine , bimatoprost , tolerability , glaucoma , timolol , ocular hypertension , intraocular pressure , open angle glaucoma , adverse effect , ophthalmology , clinical endpoint , clinical trial
To evaluate the efficacy and tolerability of the fixed combination of bimatoprost 0.03% and timolol 0.5% (BTFC) in patients in Greece with primary open angle glaucoma (POAG) or ocular hypertension (OHT) whose previous therapy provided insufficient lowering of intraocular pressure (IOP).